FDA Questioned About Plans To Investigate GSK For Hiding Cancer Risk from Zantac
Rep. Rose DeLauro says GlaxoSmithKline profited from hiding Zantac cancer risks and attempted to discredit evidence the heartburn drug contained cancer-causing chemicals.